Article
Drug-sensing hydrogels for the inducible release of biopharmaceuticals.
Department of Cranio-Maxillofacial Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091 Zurich, Switzerland.
Nature Material (impact factor:
32.84).
09/2008;
7(10):800-4.
DOI:10.1038/nmat2250
pp.800-4
Source: PubMed
-
Citations (0)
- Cited In (5)
-
Article: Emerging technologies for enabling proangiogenic therapy.
[show abstract] [hide abstract]
ABSTRACT: Ischemic disease causes a large number of deaths and significant clinical problems worldwide. Therapeutic angiogenesis, strengthened by advances in growth-factor-based therapies, is a promising solution to ischemic pathologies. Major challenges in therapeutic angiogenesis are the lack of stability of native angiogenic proteins and also providing sustained delivery of biologically active proteins at the ischemic sites. This paper will discuss various protein engineering strategies to develop stabilized proangiogenic proteins and several biomaterial technologies used to amplify the angiogenic outcome by delivering biologically active growth factors in a sustained manner.Nanotechnology 12/2011; 22(49):494004. · 3.98 Impact Factor -
Article: The food additive vanillic acid controls transgene expression in mammalian cells and mice.
[show abstract] [hide abstract]
ABSTRACT: Trigger-inducible transcription-control devices that reversibly fine-tune transgene expression in response to molecular cues have significantly advanced the rational reprogramming of mammalian cells. When designed for use in future gene- and cell-based therapies the trigger molecules have to be carefully chosen in order to provide maximum specificity, minimal side-effects and optimal pharmacokinetics in a mammalian organism. Capitalizing on control components that enable Caulobacter crescentus to metabolize vanillic acid originating from lignin degradation that occurs in its oligotrophic freshwater habitat, we have designed synthetic devices that specifically adjust transgene expression in mammalian cells when exposed to vanillic acid. Even in mice transgene expression was robust, precise and tunable in response to vanillic acid. As a licensed food additive that is regularly consumed by humans via flavoured convenience food and specific fresh vegetable and fruits, vanillic acid can be considered as a safe trigger molecule that could be used for diet-controlled transgene expression in future gene- and cell-based therapies.Nucleic Acids Research 12/2011; 40(5):e37. · 8.03 Impact Factor -
Article: In situ supramolecular assembly and modular modification of hyaluronic acid hydrogels for 3D cellular engineering.
[show abstract] [hide abstract]
ABSTRACT: A facile in situ supramolecular assembly and modular modification of biocompatible hydrogels were demonstrated using cucurbit[6]uril-conjugated hyaluronic acid (CB[6]-HA), diaminohexane-conjugated HA (DAH-HA), and tags-CB[6] for cellular engineering applications. The strong and selective host-guest interaction between CB[6] and DAH made possible the supramolecular assembly of CB[6]/DAH-HA hydrogels in the presence of cells. Then, the 3D environment of CB[6]/DAH-HA hydrogels was modularly modified by the simple treatment with various multifunctional tags-CB[6]. Furthermore, we could confirm in situ formation of CB[6]/DAH-HA hydrogels under the skin of nude mice by sequential subcutaneous injections of CB[6]-HA and DAH-HA solutions. The fluorescence of modularly modified fluorescein isothiocyanate (FITC)-CB[6] in the hydrogels was maintained for up to 11 days, reflecting the feasibility to deliver the proper cues for cellular proliferation and differentiation in the body. Taken together, CB[6]/DAH-HA hydrogels might be successfully exploited as a 3D artificial extracellular matrix for various tissue engineering applications.ACS Nano 03/2012; 6(4):2960-8. · 10.77 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
aminocoumarin antibiotic coumermycin
antibiotic-sensing hydrogel
bacterial gyrase subunit B
cellular receptors
clinically validated novobiocin
drugs
entrapped protein pharmaceutical VEGF(121)
GyrB subunits
human umbilical vein endothelial cells
human vascular endothelial growth factor
hydrogel formation
materials science
novel design concepts
potent pharmacologic mode
protein-protein interactions
regulating cell fate
smart devices
stimuli-sensing materials
stimuli-sensing smart hydrogels
time-dependent liberation